Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Marcus

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Molecular and Cellular Endocrinology|June 1, 1995
Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimersC J Winrow, K S Miyata, S L Marcus, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenaseB Zhang, S L Marcus, F G Sajjadi, et al.
Journal of the American College of Nutrition|October 1, 1992
Effect of interleukin-2 on some micronutrients during adoptive immunotherapy for various cancersH Baker, S L Marcus, D P Petrylak, et al.
The Journal of Biological Chemistry|September 9, 2000
Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigDO Steele-Mortimer, L A Knodler, S L Marcus, et al.
Journal of the Society for Gynecologic Investigation|April 29, 2000
Photodynamic endometrial ablation in the nonhuman primateD A Van Vugt, A Krzemien, B N Roy, et al.
Cancer Research|August 1, 1987
Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, J P Dutcher, E Paietta, et al.
Gut|October 18, 2000
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trialR Ackroyd, N J Brown, M F Davis, et al.
The American Journal of Clinical Nutrition|December 1, 1991
Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, D P Petrylak, J P Dutcher, et al.
Infection and Immunity|May 4, 1999
Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7G Govoni, F Canonne-Hergaux, C G Pfeifer, et al.
Nature Structural Biology|October 31, 2001
Structural and biochemical characterization of the type III secretion chaperones CesT and SigEY Luo, M G Bertero, E A Frey, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Molecular and Cellular Endocrinology|June 1, 1995
Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimersC J Winrow, K S Miyata, S L Marcus, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenaseB Zhang, S L Marcus, F G Sajjadi, et al.
Journal of the American College of Nutrition|October 1, 1992
Effect of interleukin-2 on some micronutrients during adoptive immunotherapy for various cancersH Baker, S L Marcus, D P Petrylak, et al.
The Journal of Biological Chemistry|September 9, 2000
Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigDO Steele-Mortimer, L A Knodler, S L Marcus, et al.
Journal of the Society for Gynecologic Investigation|April 29, 2000
Photodynamic endometrial ablation in the nonhuman primateD A Van Vugt, A Krzemien, B N Roy, et al.
Cancer Research|August 1, 1987
Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, J P Dutcher, E Paietta, et al.
Gut|October 18, 2000
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trialR Ackroyd, N J Brown, M F Davis, et al.
The American Journal of Clinical Nutrition|December 1, 1991
Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, D P Petrylak, J P Dutcher, et al.
Infection and Immunity|May 4, 1999
Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7G Govoni, F Canonne-Hergaux, C G Pfeifer, et al.
Nature Structural Biology|October 31, 2001
Structural and biochemical characterization of the type III secretion chaperones CesT and SigEY Luo, M G Bertero, E A Frey, et al.
Pageof 8